Skip to content

Oncology

Neutropenia Management

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. (opens new window)

Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C; European Organisation for Research and Treatment of Cancer.

Source‎: Eur J Cancer 2011;47(1):8-32.

Indexed‎: PubMed 21095116

DOI‎: 10.1016/j.ejca.2010.10.013

https://www.ncbi.nlm.nih.gov/pubmed/21095116 (opens new window)

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. (opens new window)

Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR; Infectious Diseases Society of America.

Source‎: Clin Infect Dis 2011;52(4):427-31.

Indexed‎: PubMed 21205990

DOI‎: 10.1093/cid/ciq147

https://www.ncbi.nlm.nih.gov/pubmed/21205990 (opens new window)

High-dose chemotherapy without transfusion for Philadelphia chromosome negative B-cell acute lymphoblastic leukemia in two Jehovah's Witnesses patients: a feasible option in the age of hematopoietic growth factors. (opens new window)

Perol L, Grignano E, Contejean A, Gastaud L, Legoff M, Franchi P, Deau-Fischer B, Willems L, Bouscary D, Tamburini J

Source‎: Leuk Lymphoma. 2019;60(9):2324-7.

Indexed‎: PubMed 30773115

DOI‎: 10.1080/10428194.2019.1577414

https://www.ncbi.nlm.nih.gov/pubmed/30773115 (opens new window)

Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline Update. (opens new window)

Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ, Goldberg JM, Khatcheressian JL, Leighl NB, Perkins CL, Somlo G, Wade JL, Wozniak AJ, Armitage JO; American Society of Clinical Oncology.

Source‎: J Clin Oncol 2015;33(28):3199-212.

Indexed‎: PubMed 26169616

DOI‎: 10.1200/JCO.2015.62.3488

https://www.ncbi.nlm.nih.gov/pubmed/26169616 (opens new window)

ONCOLOGY
Neutropenia Management
English
Neutropenia Management
https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

Hospital Liaison Committee (HLC)

Contact local representatives who provide free assistance to clinicians treating Jehovah’s Witnesses.

Contact

Medical Information Packets

Subjects include: Clinical strategies for managing hemorrhage and anemia without blood transfusion, the religious and ethical position of Jehovah’s Witnesses on medical therapy, and the services Witnesses offer to the medical community through their worldwide network of Hospital Liaison Committees.

View Downloads

Videos

Treatment options as well as medical and ethical considerations for clinicians who treat Jehovah’s Witnesses.

View Videos